Extended half‐life upon binding of destabilized intrabodies allows specific detection of antigen in mammalian cells
暂无分享,去创建一个
Etienne Weiss | Christian D Muller | E. Weiss | C. Muller | Jérôme Courtête | A. Sibler | G. Zeder‐Lutz | Gabrielle Zeder-Lutz | Annie-Paule Sibler | Jérôme Courtête
[1] B. Deroo,et al. Proteasome Inhibitors Reduce Luciferase and β-Galactosidase Activity in Tissue Culture Cells* , 2002, The Journal of Biological Chemistry.
[2] T. Rabbitts,et al. De novo production of diverse intracellular antibody libraries. , 2003, Nucleic acids research.
[3] G. M. Leclerc,et al. Development of a destabilized firefly luciferase enzyme for measurement of gene expression. , 2000, BioTechniques.
[4] R. Deshaies,et al. A Proteasome Howdunit The Case of the Missing Signal , 2000, Cell.
[5] E. Weiss,et al. Production of fluorescent single-chain antibody fragments in Escherichia coli. , 2000, Protein expression and purification.
[6] M. Sierks,et al. A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed α-synuclein , 2004 .
[7] A. Verkman. Diffusion in cells measured by fluorescence recovery after photobleaching. , 2003, Methods in enzymology.
[8] A. Schots,et al. Formation of Disulfide Bridges by a Single-chain Fv Antibody in the Reducing Ectopic Environment of the Plant Cytosol* , 2002, The Journal of Biological Chemistry.
[9] David W. Colby,et al. Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[10] A. Varshavsky,et al. In vivo half-life of a protein is a function of its amino-terminal residue. , 1986, Science.
[11] P. Martineau,et al. Nucleocytoplasmic shuttling of antigen in mammalian cells conferred by a soluble versus insoluble single-chain antibody fragment equipped with import/export signals. , 2003, Experimental cell research.
[12] T. Terwilliger,et al. Rapid protein-folding assay using green fluorescent protein , 1999, Nature Biotechnology.
[13] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[14] C. Tyler-Smith,et al. Attenuation of green fluorescent protein half-life in mammalian cells. , 1999, Protein engineering.
[15] A. Rajpal,et al. Intracellular Stability of Anti-caspase-3 Intrabodies Determines Efficacy in Retargeting the Antigen* , 2001, The Journal of Biological Chemistry.
[16] G. V. Shpakovski,et al. A human RNA polymerase II subunit is encoded by a recently generated multigene family , 2001, BMC Molecular Biology.
[17] E. Weiss,et al. Preferential nuclear localization of the human papillomavirus type 16 E6 oncoprotein in cervical carcinoma cells. , 2003, The Journal of general virology.
[18] D. Danley,et al. Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellular retargeting of its antigen, caspase-7. , 1999, Journal of immunological methods.
[19] A. Cattaneo,et al. Intracellular antibodies for proteomics☆ , 2004, Journal of Immunological Methods.
[20] M. Stocks. Intrabodies: production and promise. , 2004, Drug discovery today.
[21] D. Wolf,et al. Proteasomes: destruction as a programme. , 1996, Trends in biochemical sciences.
[22] Aaron Ciechanover,et al. The ubiquitin–proteasome pathway: on protein death and cell life , 1998, The EMBO journal.
[23] S. Matsufuji,et al. Degradation of ornithine decarboxylase by the 26S proteasome. , 2000, Biochemical and biophysical research communications.
[24] M. Sierks,et al. A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.
[25] B. Goud,et al. Recombinant Antibodies Against Subcellular Fractions Used to Track Endogenous Golgi Protein Dynamics in Vivo , 2003, Traffic.
[26] T. Rabbitts,et al. Intracellular antibody-caspase-mediated cell killing: an approach for application in cancer therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[27] Mingsheng Zhang,et al. Determinants of proteasome recognition of ornithine decarboxylase, a ubiquitin‐independent substrate , 2003, The EMBO journal.
[28] D. Duché,et al. Intracellular Immunization of Prokaryotic Cells against a Bacteriotoxin , 1998, Journal of bacteriology.
[29] A. Goldberg,et al. Proteasome inhibitors: valuable new tools for cell biologists. , 1998, Trends in cell biology.
[30] S. Rogers,et al. PEST sequences and regulation by proteolysis. , 1996, Trends in biochemical sciences.
[31] R. Kontermann. Intrabodies as therapeutic agents. , 2004, Methods.
[32] J. Neefjes,et al. From fixed to FRAP: measuring protein mobility and activity in living cells , 2001, Nature Cell Biology.
[33] Gösta Winberg,et al. NotI passporting to identify species composition of complex microbial systems. , 2003, Nucleic acids research.
[34] T. Rabbitts,et al. Intracellular antibodies and challenges facing their use as therapeutic agents. , 2003, Trends in molecular medicine.
[35] P. Martineau,et al. Expression of an antibody fragment at high levels in the bacterial cytoplasm. , 1998, Journal of molecular biology.
[36] R. Kopito,et al. Impairment of the ubiquitin-proteasome system by protein aggregation. , 2001, Science.
[37] E. Kabat,et al. Sequences of proteins of immunological interest , 1991 .
[38] S. Kain,et al. Generation of Destabilized Green Fluorescent Protein as a Transcription Reporter* , 1998, The Journal of Biological Chemistry.
[39] R. Chiaraluce,et al. A semi-synthetic repertoire of intrinsically stable antibody fragments derived from a single-framework scaffold. , 2001, Journal of molecular biology.